These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2576866)

  • 1. Efficacy of inactivated vaccine containing cyto-hemagglutinin against epidemic hemorrhagic fever in rabbits.
    Zhu ZY; Tang HY; Li YJ; Weng JQ; Fu GM
    Chin Med J (Engl); 1989 Aug; 102(8):602-5. PubMed ID: 2576866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans.
    Zhu ZY; Tang HY; Li YJ; Weng JQ; Yu YX; Zeng RF
    Chin Med J (Engl); 1994 Mar; 107(3):167-70. PubMed ID: 7916278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses to inactivated vaccine in people naturally infected with hantaviruses.
    Lu Q; Zhu Z; Weng J
    J Med Virol; 1996 Aug; 49(4):333-5. PubMed ID: 8877768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS).
    Song G; Huang YC; Hang CS; Hao FY; Li DX; Zheng XL; Liu WM; Li SL; Huo ZW; Huei LJ
    Vaccine; 1992; 10(4):214-6. PubMed ID: 1348595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effectiveness of Inactivated Hantavirus Vaccine Against Hemorrhagic Fever With Renal Syndrome.
    Jung J; Ko SJ; Oh HS; Moon SM; Song JW; Huh K
    J Infect Dis; 2018 Apr; 217(9):1417-1420. PubMed ID: 29373686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax).
    Cho HW; Howard CR
    Vaccine; 1999 Jun; 17(20-21):2569-75. PubMed ID: 10418904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Observational and experimental studies on relationship between domestic pigs and epidemic hemorrhagic fever investigation].
    Zhang Y; Li X; Tang J
    Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Nov; 29(6):344-7. PubMed ID: 8697938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Safety and immunogenicity of inactivated bivalent EHF vaccine in humans].
    Liu W; Xu X; Ruan Y; Weng S; Liu W; Zhou W; Dong G; Gu H; Zhu Z; Xu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):445-7. PubMed ID: 11860832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Real-time PCR assay development for the control of vaccine against hemorrhagic fever with renal syndrome].
    Egorova MS; Kurashova SS; Ishmukhametov AA; Balovneva MV; Deviatkin AA; Safonova MV; Ozherelkov SV; Khapchaev YK; Balkina AS; Belyakova AV; Dzagurova TK; Tkachenko EA
    Vopr Virusol; 2021 Mar; 66(1):65-73. PubMed ID: 33683067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive effects of three kinds of inactive vaccines against epidemic hemorrhagic fever (EHF) after 5 years of vaccination].
    Chen H; Tang L; Luo Z; Zhang J; Zhang Z; Hu M; Weng J; Liu W; Zhao T; Liu W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Oct; 21(5):347-8. PubMed ID: 11860813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome.
    Yamanishi K; Tanishita O; Tamura M; Asada H; Kondo K; Takagi M; Yoshida I; Konobe T; Fukai K
    Vaccine; 1988 Jun; 6(3):278-82. PubMed ID: 3138829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differentiation of the type of EHF antibodies by RPHI].
    Li XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):238-40. PubMed ID: 2572325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivated eastern equine encephalomyelitis vaccines prepared in monolayer and concentrated suspension chick embryo cultures.
    White A; Berman S; Lowenthal JP
    Appl Microbiol; 1971 Nov; 22(5):909-13. PubMed ID: 5132097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic difference between viral strains causing classical and mild types of epidemic hemorrhagic fever with renal syndrome in China.
    Song G; Hang CS; Liao HX; Fu JL; Gao GZ; Qiu HL; Zhang QF
    J Infect Dis; 1984 Dec; 150(6):889-94. PubMed ID: 6150062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine.
    Yoo YC; Yoshimatsu K; Koike Y; Hatsuse R; Yamanishi K; Tanishita O; Arikawa J; Azuma I
    Vaccine; 1998; 16(2-3):216-24. PubMed ID: 9607033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of an inactivated vaccine against hantaviruses.
    Cho HW; Howard CR; Lee HW
    Intervirology; 2002; 45(4-6):328-33. PubMed ID: 12602351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leptotrombidium scutellare in transmission of epidemic hemorrhagic fever virus].
    Wu G
    Zhonghua Yi Xue Za Zhi; 1992 Aug; 72(8):481-3, 510. PubMed ID: 1363219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversed passive hemagglutination and inhibition with Rift Valley fever and Crimean-Congo hemorrhagic fever viruses.
    Swanepoel R; Struthers JK; McGillivray GM
    Am J Trop Med Hyg; 1983 May; 32(3):610-7. PubMed ID: 6407347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on immunogenicity and safety of bivalent inactivated vaccine against hemorrhagic fever with renal syndrome].
    Ruan Y; Xu X; Liu W; Deng X; Weng S; Zhou W; Wang Q; Chen L; Fang L; Xu Z; Yan Q; Liu W; Dong G; Gu H; Yu Y; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):340-2. PubMed ID: 11864504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Passage adaptability of candidate strains for hemorrhagic fever with renal syndrome purified vaccine in Vero cells and their immunogenicity].
    Chen W; Xue CF; Liu JQ; Li ZY; Fan YX; Xu L; Liao H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):129-32. PubMed ID: 12869992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.